The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT
NCT05675826 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2023-01-12
Summary
This study was conducted to observe whether COVID-19 can be transmitted through stem cell transplantation and whether COVID-19-positive donors have an effect on early hematopoietic reconstitution and immune reconstitution in the recipients.
Conditions
- COVID-19
- Hematopoietic Stem Cell Transplantation
Sponsors & Collaborators
-
Chen Suning
lead OTHER
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-26
- Primary Completion
- 2023-01-31
- Completion
- 2023-04-30
Countries
- China
Study Locations
More Related Trials
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience
NCT05088941 ·Status: COMPLETED
-
Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease
NCT05531266 ·Status: UNKNOWN ·Phase: NA
-
The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
NCT06558253 ·Status: RECRUITING ·Phase: PHASE1
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING
-
Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19
NCT04349540 ·Status: UNKNOWN
-
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
NCT06856226 ·Status: RECRUITING
-
Effectiveness of COVID-19 Vaccine in Hematopoietic Stem Cell Transplant Patients
NCT05185817 ·Status: UNKNOWN ·Phase: PHASE2
-
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
NCT04428918 ·Status: WITHDRAWN
-
Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients
NCT03659773 ·Status: COMPLETED ·Phase: NA
-
Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant Recipients
NCT00026767 ·Status: COMPLETED
-
DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.
NCT03871296 ·Status: UNKNOWN
-
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745 ·Status: COMPLETED
-
Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study
NCT06386445 ·Status: NOT_YET_RECRUITING
-
Effects of Stem Cell Transplantation on Bacteria in the Mouth
NCT00476450 ·Status: COMPLETED
-
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets
NCT01687231 ·Status: COMPLETED ·Phase: NA
-
Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
NCT06143501 ·Status: RECRUITING
-
The Association of Microbiota Composition With cGVHD After Allo-HSCT
NCT05355675 ·Status: UNKNOWN
-
Co-transplantation of MSC in the Setting of Allo-HSCT
NCT04247945 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Immunomonitoring After Hematopoietic Stem Cell Transplantation
NCT04635397 ·Status: ACTIVE_NOT_RECRUITING
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
NCT06900114 ·Status: COMPLETED
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Invasive Fungal Infections in Patients Following Stem Cell Transplant
NCT04619147 ·Status: COMPLETED